Ovarian Cancer - Nov 15, 2022 - Newly developed chemical compounds show promise as potential anticancer therapy

Can't see this email? View it online

	Ovarian Cancer
	The latest ovarian cancer news from News Medical

	Newly developed chemical compounds show promise as potential anticancer therapy A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.

	Race affects care for ovarian cancer patients, study finds Non-Hispanic Black patients are less likely to receive guideline-appropriate treatment for ovarian cancer than non-Hispanic White patients, significantly affecting their treatment quality and survival chances.

	New evidence on how intermittent fasting impacts women's reproductive hormones Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones.

	Pitt researchers receive $792,000 to understand the biology behind ovarian cancer metastasis Most women diagnosed with metastatic ovarian cancer have a less than five year survival rate. Researchers at the University of Pittsburgh Swanson School of Engineering are working to change that.

	New evaluation data shows the clinical utility of SOPHiA DDM Dx HRD Solution SOPHiA GENETICS, a cloud-native software company in the healthcare space, debuted new data at the European Society of Gynaecological Oncology (ESGO) Congress as part of a poster (#PA-065) presented by Prof. Alexandre Harlé of the Institut de Cancérologie de Lorraine, France.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions